Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Immunotherapy in Lymphoma — Stella

Home/Relapsed/refractory High Grade B Cell Lymphoma/Immunotherapy in Lymphoma

View on ClinicalTrials.gov

Recruiting

Back to Relapsed/refractory High Grade B Cell Lymphoma trials

Immunotherapy in Lymphoma

Trial locations(2 sites)

South Korea

Seoul St. Mary Hospital, Seoul

Yeoido St. Mary Hospital, Seoul

Key details

Sponsor

Sung-Soo Park

Collaborators

Yeouido St. Mary's Hospital

Enrollment target

~72 participants

Started

June 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years – 74 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.